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ColonSince aberrant wound healing and chronic inﬂammation can promote malignant transformation, we deter-
mined whether dietary bioactive ﬁsh oil (FO)-derived n−3 polyunsaturated fatty acids (n−3 PUFA) modu-
late stem cell kinetics in a colitis-wounding model. Lgr5-LacZ and Lgr5-EGFP-IRES-creERT2 mice were fed
diets enriched with n−3 PUFA vs n−6 PUFA (control) and exposed to dextran sodium sulfate (DSS) for
5 days in order to induce crypt damage and colitis throughout the colon. Stem cell number, cell proliferation,
apoptosis, expression of stem cell (Lgr5, Sox9, Bmi1, Hopx, mTert, Ascl2, and DCAMKL-1) and inﬂammation
(STAT3) markers were quantiﬁed. DSS treatment resulted in the ablation of Lgr5+ stem cells in the distal
colon, concurrent with the loss of distal crypt structure and proliferating cells. Lgr5, Ascl2 and Hopx mRNA
expression levels were decreased in damaged colonic mucosa. Lgr5+ stem cells reappeared at day 5 of DSS
recovery, with normal levels attained by day 6 of recovery. There was no effect of diet on the recovery of
stem cells. FO fed animals exhibited higher levels of phospho-STAT3 at all time points, consistent with a
higher wounding by DSS in FO feeding. n−3 PUFA-fed mice exhibited a reduction in stem cell associated fac-
tors, Ascl2, Axin2 and EphB3. These results indicate that rapidly cycling Lgr5+ stem cells residing at position 1
in the colon epithelium are highly susceptible to DSS-induced damage and that dietary cues can impact stem
cell regulatory networks.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
“Adult” somatic stem cells of the colon are of particular interest
because they sustain self-renewal and are target cells for cancer
initiating mutations [1,2]. Therefore, perturbations in stem cell
dynamics are generally believed to represent the earliest step
towards colon tumorigenesis. Exciting advances have been made in
the identiﬁcation of stem cells which replenish the intestinal epithe-
lium every 3–5 days [3]. Although the exact identity of intestinal
stem cells has proven controversial over the last 30 years, rapidly cy-
cling crypt base columnar (CBC) Lgr5/GPR49 cells self-renew, active-
ly divide, and give rise to all epithelial subtypes in the small intestine
and colon [3–7]. Recent evidence indicates that intestinal crypt ho-
meostasis results from neutral competition between symmetrically
dividing Lgr5+ stem cells [8]. By crossing stem-cell-speciﬁc Lgr5-n oil; FO, ﬁsh oil; DSS, dextran
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l rights reserved.EGFP-IRES-creERT2 knockin mice to Apcﬂox/ﬂox mice, it was unequiv-
ocally shown that crypt Lgr5+ stem cells are the cells-of-origin of in-
testinal cancer [4]. Collectively, these ﬁndings lend support to the
cancer stem cell concept, i.e., that in some circumstances, normal in-
testinal stem/progenitor cells can initiate colon tumorigenesis and
drive cancer progression towards metastasis [9–11]. Emerging evi-
dence indicates that both quiescent +4 cells and CBCs have cooper-
ative functional roles, exhibiting bi-directional lineage relationships
in the small intestine and to some degree in the colon [8,12–16].
Hence, it is now possible for the ﬁrst time to visualize stem cells
and examine their behavior in the context of tissue remodeling and
cancer chemoprevention.
There is substantial experimental, epidemiological and clinical
evidence indicating that ﬁsh oil-containing diets rich in n−3
polyunsaturated fatty acids (PUFA), e.g. docosahexaenoic acid (DHA,
22:6Δ4,7,10,13,16,19) and eicosapentaenoic acid (EPA, 20:5Δ5,8,11,14,17),
are protective against colon tumorigenesis [17–25]. In a major recent
ﬁnding, it was demonstrated that EPA reduced rectal polyp number
and size in patients with familial adenomatous polyposis (FAP) [25].
Most impressive was the fact that ﬁsh oil derived n−3 PUFA
suppressed FAP to a degree similar to the selective COX-2 inhibitor
celecoxib. Collectively, these data indicate that n–3 PUFA hold promise
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tion, we have recently demonstrated that n−3 PUFA impact genes
which modulate the colon stem cell niche and tumor evolution,
e.g., Wnt/TCF signature, Ephrin B1, BMP-4, and PGE2 [26–29].
Despite the fact that aberrant wound healing/crypt regeneration
can promote malignant transformation [27,30,31], how the colonic
stem cell population responds to environmental factors such as diet
and chronic inﬂammation is not well understood. Therefore, we
hypothesized that the chemoprotective effect of EPA and DHA may
be attributed to a reduction in stem cell damage. Since little is
known regarding homeostasis within the stem cell compartment in
the large bowel, we examined the effect of dietary bioactive agents,
i.e., EPA/DHA, on stem cell kinetics in a colitis-wounding model.
These experiments are highly relevant because the effects of dietary
cues in the context of DSS-induced damage on stem cell cytokinetics
and regulatory networks in the large intestine have not been reported
to date.2. Materials and methods
2.1. Animals and DSS treatment
All procedures involving animals followed the guidelines approved
by the Institutional Animal Care and Use Committee at Texas A&M
University in accordance with EU Directive 2010/63/EU for animal
experiments. Lgr5-EGFP-IRES-creERT2 and LacZ-Lgr5 mice, originally
described by Barker et al. [3,5] (13–18 wk of age) were fed experimen-
tal diets for oneweek prior to initiation of dextran sodium sulfate (DSS)
treatment at 2.5% in drinking water, the only source of ﬂuid during the
treatment period. After 5 days of DSS treatment, plain water was pro-
vided during the DSS recovery period. Mice (n=3–5 per diet group
and time point) were terminated on days 1–7 of DSS recovery, with
EdU injected 2 h prior to termination in order to assess cell proliferation
as previously described [32]. Untreated control mice were provided
with tap water for the entire study period.2.2. Experimental diets
Diets varied only in type of lipid. Experimental diets consisted of (by
weight): 20% casein, 42% sucrose, 22% corn starch, 6% cellulose, 3.5%
AIN-76A salt mix, 1% AIN-76A vitamin mix, 0.3% DL-methionine, 0.2%
choline chloride, and 5% fat. The corn oil (CO) diet contained 5% corn
oil (Dyets, Bethlehem, PA) and the vacuum deodorized Menhaden ﬁsh
oil (FO) diet contained 4% ﬁsh oil (Omega Protein, Houston, TX) plus
1% corn oil. All diet ingredients except oils were obtained from
Bio-Serv (Frenchtown, NJ). Three ﬁsh oil fed/DSS treatedmice died dur-
ing the study and were replaced. Control animals (no DSS treatment)
were also fed either the CO or FO diets.2.3. Tissue samples
Upon termination, the colon was removed, cut open, cleaned in
PBS, placed lumen side up and cut in half longitudinally. Each half
was Swiss rolled, half being ﬁxed in 4% PFA in PBS for 4 h at 4 °C, em-
bedded in parafﬁn and used for immunohistochemistry assays. The
other half was ﬁxed in 1% formaldehyde/0.2% gluteraldehyde/0.02%
NP-40 in PBS for 2 h at 4 °C for LacZ staining. On a separate set of
mice (n=5) receiving the same diet and treatment regimen, colons
were removed, cut open and cleaned in PBS, the mucosal layer was
scraped with a microscope slide and total RNA was isolated using
an Ambion mirVana kit followed by DNase treatment with Ambion
DNAFree. RNA quality was assessed by Agilent Bioanalyzer and all
samples had an RIN score greater than 9.0.2.4. Immunohistochemistry
Cell proliferationwasmeasured using the Click-IT EdUkit (Invitrogen,
Carlsbad, CA) as per manufacturer's instructions on formalin ﬁxed paraf-
ﬁn embedded (FFPE) sections. Apoptosis was assessed with the TACS 2
TdT TUNEL assay (Trevigen, Gaithersburg, MD) [33]. LacZ positive stem
cells were detectedwith β-galactosidase staining as previously described
[4]. Phospho-STAT3, Sox9 and DCAMKL1 were detected in FFPE sections
after retrieval in 10 mM Tris base/1 mM EDTA (phospho-STAT3 and
DCAMKL1) or 10 mM sodium citrate (Sox9) for 20 min in a sub-boiling
bath. Primary antibodies were as follows: Phospho-STAT3 (Tyr705), Cell
Signaling, 1:200 dilution; Sox9, Millipore, 1:1000 dilution; DCAMKL1,
Abcam, 1:100 dilution. Prior to primary antibody incubation, an Image-iT
FX signal enhancer (Invitrogen) was used for phopho-STAT3 and Sox9
slides. Goat–anti-rabbit secondary antibody conjugated with Alexa-647
(Invitrogen) was used on all slides. For quantiﬁcation of phospho-STAT3
expression, intensity of staining was measured using NIS Elements AR
software on a Nikon Ti-E inverted microscope equipped with an X-cite
120 ﬂuorescent microscopy illuminator using a 20× objective. Ten mea-
surements were taken from each proximal or distal segment from each
animal in order to determine average epithelial phospho-STAT3
expression.2.5. Flow cytometry
Following tamoxifen induction, colonic crypts were isolated by the
method of Sato et al. [7] with minor modiﬁcation. The intact colons
were everted on a disposable mouse gavage needle (Instech Laborato-
ries) and incubated with 20 mM EDTA in PBS at 37 °C for 30 min.
Following transfer to chilled Ca/Mg free HBSS, colons were vigorously
vortexed to release crypts. The ﬁnal crypt fraction was incubated with
trypsin/DNase to produce a single cell suspension for ﬂow cytometry
of GFP positive cells using an Accuri C6 ﬂow cytometer (BD Biosci-
ences). In addition, for stem cell sorting, GFPhigh expressing stem cells
and GPFnegative cells from the small intestine and colon were separately
isolated using a BD FACSAria II cytometer/sorter (BD Biosciences).2.6. Real time PCR
Gene expression was quantiﬁed by TaqMan assay using an ABI
7900HT (Applied Biosystems) on control mice (no DSS treatment)
and at 3 days of DSS recovery (n=5 per treatment and diet). Assays
were tested for proportionality and efﬁciency prior to use and negative
controls, omitting the reverse transcriptase enzyme, were performed
for all genes. Gene expression was quantiﬁed for the following genes:
Ascl2, Axin2, Bmi1, Eph3, Hopx, Lgr5, mTert, Rspo1, Sox9, Stat3 and
18S (for normalization). Because Rspo1 was nearly undetectable, quan-
tiﬁcationwas repeated on a Bio-Rad QX-100 Droplet Digital PCR system
using the same TaqMan assay.2.7. RNA sequencing
RNA (80 ng) was converted to cDNA using the NuGEN Ovation
3′-DGE kit. Three micrograms of cDNA was then fragmented (Covaris).
The fragmented sample was quantiﬁed with the Quant-IT Picogreen kit
(Invitrogen) and evaluated for proper fragmentation of 150 to 200 bp
on an Agilent Bioanalyzer DNA 1000 chip. Subsequently, 200 ng
sheared double stranded cDNAwas used for the Encore Library System
I kit (NuGEN) to create the Illumina libraries as per manufacturer's in-
structions. Libraries were quantiﬁed by Quant-IT and run on an Agilent
DNA Chip 1000 to conﬁrm appropriate size and absence of adapter di-
mers. Samples were sequenced on an Illumina GAII with single end,
75 bp reads.
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Data analyses were performed using either the exact Wilcoxon
two-sample test or one-way ANOVA with Tukey's adjustment for
multiple comparisons using SAS 9.2.
3. Results
DSS treatment resulted in the ablation of LacZ positive-Lgr5+ stem
cells in the distal colon (Fig. 1A), concurrent with the extensive loss of
distal crypt structure. In contrast, the proximal colon was protected
from DSS damage, maintaining ~4–6 stem cells per crypt after the
ﬁrst day of DSS recovery, similar to untreated control animals (Fig.
1A and B). Similar results were observed using ﬂow cytometric anal-
ysis of Lgr5 EGFP+ colonic epithelial cells (Fig. 1C). Stem cells in the
distal colon, almost completely absent from days 1 to 4 of DSS recov-
ery, reappeared at day 5, with higher than normal levels attained by
days 6–7 of recovery. There was no difference in recovery of stem
cells between the n−3 and n−6 PUFA groups (Fig. 1B).Fig. 1. Detection of Lgr5+ stem cells during recovery from DSS treatment. Animals were tre
“recovery” phase. A, representative photomicrographs depicting β-galactosidase staining of L
(c) DSS treated, 7‐day recovery, ×100–200. B, Mean number of Lgr5+ stem cells per crypt
point. However, during days 1–4 of recovery, many animals had no scoreable crypts in the
mice. C, Representative ﬂow cytometric analysis of Lgr5 GFP+ colonic epithelial cells. a–c:
used for gating. b and e represent control animals displaying the expected levels of GFP+
fed mice.Since early alterations in cell proliferation and apoptosis occur
following damage to the colonic epithelium [34], experiments were
conducted to document the effects of DSS-induced wounding on crypt
cell cytokinetics. The percentage of crypts with proliferating cells,
i.e., crypts with EdU+ cells, remained relatively constant at 50–70%
in the proximal colon region during all 7 days of recovery, compared
to 85% of crypts containing proliferating cells in control animals. In
contrast, in the distal colon, 5–20% of the crypt area contained prolif-
erating cells during days 1–2 of recovery, increasing to 60–70% by
day 5 (Fig. 2A and B). These data indicate that, in general, the epithelial
cell cycle has been arrested. In complementary analyses, apoptosis was
measured using the dUTP nick end-labeling (TUNEL) assay. DSS expo-
sure elevated the apoptotic index equally in the proximal and distal
colon (Fig. 3). Overall, diet had no effect on crypt cell cytokinetics.
To better understand the impact of inﬂammation and dietary bio-
active agents on the colonic epithelial progenitor niche during the
regenerative response to colitis, we examined important regulators
of intestinal homeostasis after induction of wounding injury. Phospho
signal transducer and activator of transcription (pSTAT3) levels, aated with DSS for 5 days to induce colitis and terminated at daily intervals during the
gr5+ stem cells in distal colon in (a) untreated control, (b) DSS treated, 2‐day recovery,
during DSS recovery (at least 20 crypts each from n=3 mice per diet group and time
distal colon.) There were no signiﬁcant differences (P>0.05) between CO and FO fed
Distal colon; d–f: proximal colon. a and d are from wild type mice (no GFP) and were
cells, c and f are from DSS treated mice, day 1 recovery. FO, ﬁsh oil fed; CO, corn oil
Fig. 2. Detection of proliferating (EdU+) cells following DSS exposure. A, representative
photomicrographs (×100) of distal colonic crypts stained for EdU (red) with all nuclei
stained with DAPI (blue), (a) untreated control, (b) DSS treated, day 2 recovery, (c) DSS
treated, day 3 recovery, (d) DSS treated day 7 recovery. B, Mean percentage of crypts
with proliferating cells during DSS recovery. Control represents non-DSS treated mice.
There was no signiﬁcant difference between CO and FO fed mice at any time point
(p>0.05).
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crypt cell survival [35,36], were signiﬁcantly elevated compared to
untreated animals for days 1–5 of recovery, after which expression
approached control levels (Fig. 4). In general, STAT3 phosphorylation
was localized primarily to damaged and regenerating crypts (Supple-
mental Figure 1). Fish oil fed animals exhibited higher levels of
pSTAT3 compared to corn oil fed mice at all time points, consistent
with a higher wounding by DSS in ﬁsh oil feeding [37] (Fig. 4).
Sox9, a marker of cell proliferation, self-renewal and repair in the in-
testine [38,39], was strongly upregulated in recovering crypts, and
was correlated to the regeneration of the damaged tissue and the
reestablishment of Lgr5+ stem cells in the distal colon (Fig. 5). For
comparative purposes, an additional putative stem cell marker
(DCAMKL1) was assessed by IHC (Supplemental Figure 2). In general,
DCAMKL1 expression was dispersed throughout the crypt and was
not associated with damaged and regenerating crypts.
The continuous cell renewal of the intestinal epithelium is regulated
by a number of homeostatic pathways, including Wnt signaling [6].
Therefore, initially in control animals (no DSS or n−3 PUFA exposure),
we assessed the transcriptome proﬁle of stem cells (GFP high popula-
tion) as compared to GFP negative cells (non stem cell population) in
the small intestine and colon using next generation sequencing
(Table 1). Both small intestine and colon transcript GFP positive cells
were enriched in genes associated with Wnt signaling (Lgr5, BMP4)
[40], and stem cell renewal (EPHB3, HES1, SNAI2, SOX9) [38,41–43].
Interestingly, the “master” intestinal transcription factor (CDX2) [44]
was only enriched in colonic Lgr5 positive cells. We subsequently
sought to determine the combined effect of wounding injury and an
n−3 PUFA-enriched diet on the relative expression of Wnt signaling
activators; R-spondin (Rspo-1); R-spondin receptor (Lgr5) [45]; Wnt
signaling inhibitor, Axin2 [46] and intestinal stem cell associated
factors, Achaete Scute-Like 2 (Ascl2), Ephrin type-B receptor 3
(EphB3) [6], mouse telomerase reverse transcriptase (mTERT) [47],
and HOP homeobox (Hopx) [13]. At 3 days of recovery from DSS, a
time when very few Lgr5+ stem cells are detectable (Fig. 1B), Lgr5
mRNA was signiﬁcantly (Pb0.05) suppressed relative to control mice
(no DSS treatment) (Table 2). Other stem cell markers, Ascl2 and
Sox9, were similarly down regulated by DSS exposure. Interestingly,
Axin2 was suppressed, consistent with an enhancement of Wnt signal-
ing during the recovery phase. Consistent with the expression of
pSTAT3 (Fig. 4), STAT3 mRNA levels were also increased following
DSS exposure.
Since dietary FO alters the levels of genes which modulate both in-
testinal inﬂammation [27,48,49] and the stem cell niche, e.g., Wnt/
TCF signature, Ephrin B1, BMP4, and PGE2 [8,27–29], it was notewor-
thy that n−3 PUFA-fed mice exhibited a signiﬁcant (Pb0.05) reduc-
tion of Ascl2, Axin2 and EphB3 expression (Table 2).
4. Discussion
Recent ﬁndings lend support to the concept that in some circum-
stances, inﬂammation-induced wound healing/intestinal crypt re-
generation can perturb homeostasis within the stem cell compartment
and promote malignant transformation [10,27,30,31]. Therefore, it is
important to knowprecisely how intestinal stemcell populations respond
to environmental factors in the context of inﬂammation. Since little is
known regarding the homeostaticmechanismswithin the stem cell com-
partment in the large intestine, in this study we used the Lgr5-LacZ and
Lgr5-EGFP-IRES-cre knockin mouse models to examine the adult colon
stem cell response to DSS exposure and a putative therapeutic diet (ﬁsh
oil).
Exposure to DSS represents a wounding model that induces muco-
sal injury and subsequent inﬂammation via the recruitment and acti-
vation of inﬂammatory cells and mediators, ultimately leading to the
development of colitis [50]. As expected, acute DSS exposure ablated
colonic crypts in the distal colon (Fig. 1) [51]. The simultaneousabrupt reduction in crypt DNA synthesis (Fig. 2) and enhanced dele-
tion of damaged cells (Fig. 3) represents a classical manifestation of
damage to the colonic epithelium [34,52]. Since colon stem cell
kinetics have not been reported in the context of a colitis/wounding
model, in the current study we also investigated how the DSS model
impacts the colonic stem cell compartment. Rapidly cycling Lgr5+ stem
Fig. 3. Apoptotic index during recovery from DSS treatment. Data represent average
apoptotic index within diet groups over the 7 days DSS recovery period (all days com-
bined). At least 20 crypts each from n=3 mice per diet group and time point were
scored for TUNEL positive (apoptotic) cells and expressed as apoptotic index (number
of apoptotic cells per 100 crypts). Bars with different letters are statistically different
(pb0.05). Inset: Apoptosis on individual days in proximal (grey) and distal (black)
colon for both diets combined. Dotted line: untreated control mice.
Fig. 5. Effect of DSS exposure on Sox9 crypt localization. Representative photomicro-
graphs (×100) of Alexa-647 ﬂuorescently labeled distal colonic crypt cells. (a) Untreated
control, (b) DSS treated, day 1 recovery, (c) DSS treated, day 3 recovery.
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by day 5 of recovery. The elimination of stem cells and their subsequent
recovery in response to acute DSS exposure was conﬁrmed by (i) the
disappearance of Lgr5-GPF and LacZ-positive cells and (ii) the absence
of EdU at the base of crypts at positions 1–4. These data indicate that
the rapidly cycling CBC stem cell (Lgr5+) compartment located at the
base of the colonic crypt is highly susceptible to damage-induced intes-
tinal injury. It is possible that Lgr5 gene expression is selectively turned
off in response to damage, however, there is no evidence to date that
this receptor is reversibly responsive to environmental insult.
Although it is not clear why the proximal colon is resistant to the
effects of DSS, our ﬁndings extend a previous report indicating that
following γ-irradiation, Lgr5 expressing cells are eliminated [53]. Inter-
estingly, Lgr5+ cells in the small intestine are not susceptible to
Doxorubicin-induced cell death [54]. With regard to the reestablish-
ment of Lgr5+ cells, it is possible that a small number of rapidly cycling
stem cells survive insult in the crypt base and repopulate the crypts.
There is some evidence indicating that the small intestine contains
a quiescent stem cell population at 4 cells above the base of the
crypt (+4 position), e.g., Hopx, Bmi1, Lrig1, and mTert expressingFig. 4. Detection of phospho-STAT3 (Y705) following DSS exposure. Mean ﬂuorescence
intensity of proximal versus distal colon during DSS recovery (n=3 mice per diet
group, all time points combined). Inset: mean ﬂuorescence intensity across time
from pooled proximal and distal colon for corn oil (grey) and ﬁsh oil fed mice
(black). Dotted line: untreated control mice. Bars with different superscripts are signif-
icantly different at pb0.05.cells [13,15,47,55]. These slowly cycling stem cells are capable of
interconverting with more rapidly cycling Lgr5 stem cells at the
crypt base [13,15]. Therefore, a putative intestinal model of stem
cell renewal and crypt regeneration incorporates a bi-directional
lineage relationship between active and quiescent stem cells in
their niches. However, recent data imply that Bmi1, Hopx, mTert
and Lrig1 cannot be used as markers for a quiescent reserve stem
cell population [56]. This small intestinal model is further complicated
by the fact that during regenerative responses to injury, stromal stem
cells, including activated macrophages [57,58], as well as bone marrow
derived cells [59], transmit regenerative signals to neighboring colonic
epithelial progenitors. Since many of the experiments focusing on
stem cell identity and location have focused on the small intestine,
additional work is needed in order to conﬁrm these relationships in
the colon.
Examination of the Lgr5 positive cell global transcriptome in the
small intestine and colon revealed a signiﬁcant enrichment in genes re-
lated toWnt signaling and stemness (Table 1). These data are consistent
with previous targeted qPCR analyses [60]. With respect to the DSS-
induced colitis and crypt regeneration model, we showed that both
Lgr5 and Hopx mRNA expression levels were decreased in damaged
colonic mucosa (Table 2). Other Wnt targeted stem/progenitor cell
markers, Ascl2 and Sox9, were also down regulated at the mRNA level
Table 1
Gene expression by RNA sequencing of colonic and small intestinal GFPHigh stem cells
and non-stem cell (GFP negative) populations. Values are expressed as RPKM (reads
per kilobase per million mapped reads). Cells were sorted from two pooled mice.
Gene Expression in stem
cell population
(GFP high)
Expression in non stem
cell population
(GFP negative)
Fold change
(GFP high/
negative)
Colon
Adam9 18.665 5.991 3.116
Ascl2 0 0.132 0
Axin2 1.646 2.023 0.814
Bmi1 0 1.783 0
Bmp4 0.758 0.016 47.844
Cdx2 44.720 7.527 5.941
Dclk1 0 0.282 0
Ephb3 21.991 0.622 35.344
Foxn1 1.224 0.077 15.948
Hes1 46.953 5.296 8.866
Hopx 0.317 2.477 0.128
Hoxc8 1.230 0.024 51.831
Igf1 0.028 0.004 7.974
Lgr5 2.599 0.862 3.015
Lgr6 0 0 0
Lrig1 0.856 5.031 0.170
Lrig2 0.020 2.548 0.008
Lrig3 0.527 4.684 0.112
Notch4 0.106 0.067 1.595
Omlf4 0 0.041 0
Prom1 6.541 40.642 0.161
Rspo-1 0 0 0
Runx3 0.042 0.007 5.980
Smoc2 10.571 1.452 7.280
Snai2 0.588 0.052 11.296
Sox4 4.910 2.816 1.744
Sox9 51.631 4.288 12.040
Stat3 0.347 3.722 0.093
Tert 0.017 0.216 0.077
Tgfbr2 4.761 2.454 1.940
Small intestine
Adam9 1.448 2.858 0.506
Ascl2 5.776 1.064 5.426
Axin2 27.925 16.477 1.695
Bmi1 2.333 3.054 0.764
Bmp4 0.070 0 0
Cdx2 7.731 8.247 0.938
Dclk1 0.360 0.212 1.696
Ephb3 13.987 2.026 6.904
Foxn1 0.012 0.100 0.122
Hes1 42.973 8.090 5.312
Hopx 9.810 9.202 1.066
Hoxc8 0.053 0.024 2.198
Igf1 0.004 0 0
Lgr5 13.870 3.575 3.880
Lgr6 0 0 0
Lrig1 7.571 8.813 0.859
Lrig2 0.710 2.207 0.321
Lrig3 3.226 3.230 0.999
Notch4 0.108 0.103 1.051
Olfm4 647.212 678.583 0.954
Prom1 36.511 29.596 1.234
Rspo-1 0.020 0 0
Runx3 0 0.057 0
Smoc2 38.483 12.751 3.018
Snai2 0.327 0.105 3.114
Sox4 17.097 6.821 2.506
Sox9 15.853 8.702 1.822
Stat3 1.511 4.083 0.370
Tert 1.551 0.512 3.027
Tgfbr2 1.441 1.219 1.182
Table 2
mRNA expression proﬁles of stem cell mediators in colonic mucosa from control
and DSS treated mice—3 days of recovery. Real-time PCR was performed using
Taqman probes (Applied Biosystems) and expression levels were normalized to
ribosomal 18S. Values are means, n=5 mice per group. TaqMan gene expression
assay IDs were as follows: Ascl2, Mm01268891_g1; Axin2, Mm00443610_m1;
Bmi1, Mm03053308_g1; EphB3, Mm00802553_m1; Hopx, Mm00558630_m1; Lgr5,
Mm00438890_m1; mTert, Mm00436931_m1; Rspo1, Mm00507077_m1; Sox9,
Mm00448840_m1; Stat3, Mm01219775_m1; 18S, Hs99999901_s1.
Gene Diet Expression level
(% of control)
P value vs
control
P value CO vs FO
Ascl2 CO 61.3 b0.001
FO 24.1 0.002 0.016
Axin2 CO 53.1 b0.001
FO 28.8 0.002 0.016
Eph B3 CO 65.8 b0.001
FO 43.7 0.002 0.032
STAT3 CO 168.8 b0.001
FO 161.3 b0.001 0.111
Hopx CO 70.0 0.006
FO 64.7 0.002 0.191
Lgr5 CO 43.8 0.008
FO 24.1 0.002 0.191
Sox9 CO 59.9 b0.001
FO 50.8 b0.001 0.310
Rspo-1 CO 114.6 0.550
FO 128.0 0.413 0.342
mTERT CO 86.1 0.243
FO 71.6 0.122 0.421
Bmi1 CO 127.3 0.222 0.548
FO 113.2 0.030
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vated during intestinal regeneration [6,61], andmay be attributed to the
time point sampled (3 days DSS recovery). It was not surprising to see
the inverse mRNA expression of Axin2 (suppression of Wnt signaling
inhibitor) and Rspo-1 (enhancement of Wnt signaling activator)following DSS exposure. These two mediators reciprocally regulate
Wnt signaling [45,46].
To our knowledge, this is the ﬁrst study to utilize Lgr5+ reporter
mice to determine the impact of diet on intestinal stem cell survival
and gene expression. Dietary ﬁsh oil, containing long chain n−3
PUFA, has been shown to attenuate intestinal inﬂammation
[27,37,48,49], and impact genes which modulate mediators of the
colon stem cell niche, e.g., Wnt/TCF signature, Ephrin B1, BMP-4, and
PGE2, in animal models of intestinal inﬂammation/carcinogenesis
[26–29]. Therefore, we hypothesized that the protective effect of
n−3 PUFA may be partially attributed to a reduction in stem cell
damage. To our surprise, there was no difference in the recovery of
stem cells between the n−3 and n−6 PUFA groups (Fig. 1B), al-
though there was a modest elevation in the number of stem cells at re-
covery days 6 and 7 in FO fed mice. Interestingly, STAT3 activation
(Fig. 4) was highest in DSS exposed, FO-fed mice. This is noteworthy,
because STAT3 mediates immune homeostasis in the gut by promoting
mucosal wound healing and stem cell survival [35,36]. The enhance-
ment of STAT3 by n−3 PUFA is generally consistent with a higher
wounding by DSS. Indeed, we have unambiguously demonstrated that
FO feeding disrupts mucosa repair during the acute phase of DSS expo-
sure in part due to the inhibition of NF-kB activity in the colonicmucosa
[37].
FO feeding modulated the expression of genes known to regulate
the stem cell niche, e.g., Ascl2, Axin2 and Eph3 (Table 2). Further-
more, we have recently demonstrated that dietary FO modulates a
subset of non-coding microRNAs (miR 19b, 26b, 200c and 203) and
their target genes (mRNAs) implicated in the regulation of the colon
stem cell niche and tumor evolution [29]. Collectively, these results
suggest that select dietary cues can impact stem cell regulatory net-
works. Additional research is needed in order to elucidate the biolog-
ical relevance of the FO-induced changes in genes which deﬁne
intestinal stem cells.
Thepresent studyhas deﬁned the impact ofwounding/inﬂammation
and dietary n−3 PUFA on the colonic epithelial progenitor niche during
1606 L.A. Davidson et al. / Biochimica et Biophysica Acta 1822 (2012) 1600–1607the regenerative response to colitis. Since transformation of adult stem
cells is an extremely efﬁcient route towards initiating intestinal cancer
[4], including the transition from colitis to cancer [62], it is imperative
that we understand how environmental factors modulate colonic stem
cell survival and self-renewal in response to chronic inﬂammation and
carcinogen exposure.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbadis.2012.06.011.
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